Rinat Neuroscience Corporation Explained

Rinat Neuroscience Corporation was a privately held biotechnology company that discovered and developed antibody-based drugs, including:

Rinat was founded in 2001 by Arnon Rosenthal,[12] [13] who was also Rinat's president, chief scientific office and board director, and Patrick Lynn,[14] following a broad licensing agreement with Genentech,[15] and was acquired by Pfizer in 2006 for approximately $500M.[16] [17] Rinat currently operates as an independent biotechnology unit within Pfizer's Worldwide R&D group in South San Francisco.[18]

Notes and References

  1. Web site: Vastag. Brian. Monoclonals expand into neural disorders. Nature.
  2. Lane. Nancy E.. Tanezumab for the Treatment of Pain from Osteoarthritis of the Knee. New England Journal of Medicine. 363. 16. 1521–1531. The New England Journal of Medicine. etal. 10.1056/NEJMoa0901510. 20942668. 2010. 6896791. 16950684.
  3. Web site: Ponezumab. ALZForum.
  4. Web site: Teva Completes Acquisition of Labrys: Opens Door to a Strong and Novel Migraine Prevention and Treatment Franchise within its CNS Portfolio. Business Wire/Nasdaq.
  5. Web site: Carroll. John. In biotech trifecta, startup lassos $31M, a CEO and a lead drug from Pfizer. FierceBiotech.
  6. Web site: Leuty. Ron. Migraine drug developer Labrys targeted by Teva in $825 million deal. San Francisco Business Times.
  7. Web site: Berkrot. Bill. Beasley. Deena. Experimental Pfizer cholesterol drug promising in study. Reuters.
  8. Web site: An Investigational Therapy for Geographic Atrophy in Age-Related Macular Degeneration.
  9. Single and multiple ascending-dose study of glucagon-receptor antagonist RN909 in type 2 diabetes. Endocrine. 62. 2. 371–380. 10.1007/s12020-018-1597-1. 30203123. 2018. Gumbiner. Barry. Esteves. Brooke. Dell. Vanessa. Joh. Tenshang. Garzone. Pamela D.. Forgie. Alison. Udata. Chandrasekhar. 52184370 .
  10. Web site: REGN4018, a novel MUC16xCD3 bispecific T-cell engager for the treatment of ovarian cancer.
  11. Web site: FIH study of an OX40 agonist mAb PF-04518600 in adult patients with select advanced solid tumors.
  12. Web site: Arnon Rosenthal Ph.D. - Executive Profile. https://archive.today/20141026173302/http://investing.businessweek.com/research/stocks/private/person.asp?personId=27851460&privcapId=1288518. dead. October 26, 2014. Bloomberg Businessweek.
  13. Web site: Leuty. Ron. Alector snags funding in founder's latest attack on Alzheimer's. San Francisco Business Times.
  14. Web site: Patrick G. Lynn - Executive Profile. https://archive.today/20141026173235/http://investing.businessweek.com/research/stocks/private/person.asp?personId=77688&privcapId=36882503. dead. October 26, 2014. Bloomberg Businessweek.
  15. Web site: Genentech and Rinat Neuroscience Announce Co-Development and Joint Commercialization Agreement for Anti-NGF Antibody for Acute and Chronic Pain. Genentech.
  16. Web site: Pollack. Andrew. Pfizer to Buy Rinat, a Biotechnology Drug Maker. New York Times.
  17. Web site: Pfizer to Expand Neuroscience Research with Acquisition of Biotech Company Rinat Neuroscience disorders. Pfizer. dead. https://web.archive.org/web/20150924072046/http://www.pfizer.be/sites/be/nl/media/press_bulletins/research_and_development_and_business_development/Pages/Pfizertoexpandneuroscienceresearchwithacquisitionofbiotechcompanyrinatneuroscience.aspx. 2015-09-24.
  18. Web site: Rinat. Pfizer. dead. https://web.archive.org/web/20140901122043/http://www.pfizer.com/partnering/areas_of_interest/rinat. 2014-09-01.

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Rinat Neuroscience Corporation".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.